In the News
In Silico in Sight as Biopharma Game-Changer
Pharmaceutical Executive reporter discusses how a coalition of data, computational power, and AI is bringing the full potential of in silico medicine out of the realm of science fiction. Read the full story here.
read more
GNS Healthcare, MMRF Bring Patient Simulations to Multiple Myeloma Precision Treatment, Trial Design
Precision Oncology News reporter discusses Gemini and its prospective impact on multiple myeloma. Read more here.
read more
GNS Healthcare Launches Computer Model of Disease Progression, Treatment Responses in Myeloma
Myeloma Research News covers GNS launch of Gemini. Read more here.
read moreEvents
Colin Hill to Speak at 2020 STAT Health Tech Summit
This year’s 2020 STAT Health Tech Summit will engage industry leaders, from giants like Apple and Google to upstarts emerging from stealth to discuss how breakthroughs in health and medicine are not just biological – they are technological. The two-day event will...
read more
Colin Hill to Speak at MassBio’s State of Possible Conference
This year’s State of Possible Conference, MassBio's Annual Meeting, will celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate...
read more
Iya Khalil to Weigh in on How AI is Transforming Early-Stage Biotech Partnerships and Drug Discovery
Artificial Intelligence (AI) and Machine Learning (ML) are rapidly transforming industries, from autonomous cars, to logistics, to technology – and now biotechnology. Excitement about AI and ML driven solutions for accelerated drug discovery, drug development, and...
read morePress Releases
GNS to Develop the World’s First in silico Patient For Prostate Cancer
Somerville, Mass., May 25, 2021: GNS Healthcare, an artificial intelligence company creating in silico patients that simulate drug treatment at the individual patient level, today announced plans to develop and launch Gemini — The in silico Patient™ for Prostate...
read moreGNS Healthcare Hires Alan Kilyk as Chief Financial Officer
Somerville, MA: GNS Healthcare, an AI company creating in silico patients to simulate disease progression and drug treatment at the individual patient level, is pleased to announce that accomplished finance executive Alan Kilyk has joined the company’s leadership team...
read moreQIAGEN Adopts GNS Healthcare’s Gemini – The in silico Patient™ Across Multiple Cancers
Partnership enables enhanced capability to discover new targets and prognostic markers Somerville, MA: GNS Healthcare, the leading AI-driven precision medicine company, today announced a partnership with QIAGEN, the leading global provider of Sample to Insight...
read more